What CHOU2 PHARMA does

CHOU2 PHARMA is an early-stage pet health company headquartered in Philadelphia, founded in 2021 with a team of 1-10 employees. The company develops and sells natural CBD-based supplement products for pets through a marketplace distribution channel (VetCove.com), targeting pet owners seeking plant-based wellness options for their animals. Its core business model is direct-to-consumer supplement sales via an online marketplace partnership, with a stated 'Shop Now' call-to-action routing buyers to VetCove.com.

In parallel with its consumer supplement line, CHOU2 PHARMA is pursuing FDA Center for Veterinary Medicine (CVM) approval for a platform of plant-based drugs intended for animals. The company has indicated that its next round of clinical data collection is underway, with the dual purpose of supporting a future drug pipeline and improving the existing supplement product line. The company is led by CEO Brian Segebrecht, and its website operates as a basic marketing and update page with minimal e-commerce functionality of its own.

The company is privately held with no disclosed investors, funding rounds, or revenue figures. Its technology differentiation is concentrated in domain specialization (animal-focused plant-based therapeutics) rather than in any disclosed proprietary platform architecture. Limited public signals — including no certifications, no patents, no app, no API, and no regulatory filings beyond the stated FDA CVM pursuit — indicate the company is currently in a pre-commercial or nascent commercial phase, with its strategic optionality tied primarily to the outcome of its clinical and regulatory milestones.

Name

CHOU2 PHARMA

Legal name

Chou2 Customer Update

Website

https://chou2pharma.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

CHOU2 PHARMA is an early-stage Philadelphia-based pet health company that sells natural CBD supplements for pets via VetCove.com and is pursuing FDA CVM approval for a platform of plant-based veterinary drugs.

Ownership category

akta.pro rank

Product category

Veterinary CBD / Pet Pharmaceuticals

NAICS

Pet and Pet Supplies Retailers (459910), Dog and Cat Food Manufacturing (311111)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

CBD/Hemp Pet Products Retail (CRANAHAF)

akta.pro secondary industries

Specialty & Condition-Specific Nutraceuticals (e.g., Liver, Eye, Endocrine) (HLAMALAO), Veterinary & Therapeutic Pet Diets (Prescription) (AFADAFAH)

Keywords

• Pet CBD products
• Veterinary CBD supplements
• Plant-based animal drugs
• Pet wellness products
• Cannabinoid veterinary care

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Pet CBD Product Sales: Chou2 Pharma generates revenue through the sale of natural CBD solutions for pets, including both supplement products and a platform of plant-based drugs for animals currently undergoing clinical data collection for FDA CVM approval.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

CHOU2 PHARMA develops and sells natural CBD-based solutions for pets and is pursuing FDA Center for Veterinary Medicine (CVM) approval for a platform of plant-based drugs for animals. The company positions itself at the intersection of consumer pet CBD wellness and regulated veterinary therapeutics.

Product overview

Chou2 Pharma offers a platform of natural CBD solutions for pets, comprising supplement products for animal wellness. The company is pursuing FDA CVM (Center for Veterinary Medicine) approval for a platform of plant-based drugs intended for animals, which will complement their existing supplement product line.

Differentiator

Problem solved

Functional benefit

Products and services

• Natural CBD Solutions for Pets Natural, plant-based (CBD) wellness products formulated for companion animals (pet owners and their dogs/cats), sold as the company's current commercial offering.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• VetCovecoreChannel Partner/ Reseller/ DistributorVetCove.com serves as Chou2 Pharma's primary distribution channel, hosting the 'Shop Now' functionality that directs consumers to purchase pet CBD products through their marketplace platform.

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• ElleVet Sciences: ElleVet Sciences is a pet CBD company that has invested heavily in clinical research and veterinary partnerships, similar to Chou2 Pharma's R&D-driven positioning. Both target the pet health CBD market with science-backed formulations and pursue veterinary channel distribution.
• Honest Paws: Honest Paws is a leading direct-to-consumer pet CBD brand offering oils, treats, and supplements for dogs and cats. It competes head-to-head with Chou2 Pharma in the pet CBD supplement category across similar condition-specific formulations.
• Pet Releaf: Pet Releaf produces full-spectrum hemp CBD products specifically formulated for pets, with an emphasis on certified organic ingredients and veterinary-grade positioning that closely mirrors Chou2 Pharma's natural, animal-focused approach.
• Canna-Pet: Canna-Pet is one of the longest-standing pet CBD brands, offering hemp-based supplements for cats, dogs, and small animals. It competes directly with Chou2 Pharma's supplement product line in the same consumer channels.
• King Kanine: King Kanine offers CBD oils, treats, and topical products for pets with a focus on natural, premium formulations. Comparable to Chou2 Pharma in product format, target customer (pet owners), and direct-to-consumer go-to-market approach.
• Treatibles: Treatibles produces hemp-derived CBD products for pets with a focus on whole-plant extracts and condition-specific formulations. Similar to Chou2 Pharma's positioning around natural, plant-based solutions targeting pet health and wellness.
• CBD Dog Health: CBD Dog Health specializes in full-spectrum hemp extract products for dogs and cats, with an emphasis on natural, plant-based wellness solutions that overlap directly with Chou2 Pharma's core offering.
• VetCBD: VetCBD offers CBD tinctures formulated specifically for pets and is positioned around veterinary endorsement, paralleling Chou2 Pharma's pursuit of legitimacy through regulatory and clinical credibility in the veterinary space.
• ElleVet Sciences: Note: ElleVet listed twice for emphasis on its clinical-research-led approach most similar to Chou2 Pharma's FDA CVM pursuit. Both companies are investing in veterinary clinical trials to differentiate from commoditized pet CBD competitors.

Emerging players

• Phyto Animal Health: Phyto Animal Health markets CBD products for pets with an emphasis on natural, plant-based ingredients. It competes with Chou2 Pharma in the consumer supplement category but with less clinical-research differentiation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/chou2pharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CHOU2 PHARMA